TH1601002196A - Use of semaphorin-4D binding molecule For the treatment of disease disorders Destruction of nerve cells in the brain (neurodegenerative disorder) - Google Patents

Use of semaphorin-4D binding molecule For the treatment of disease disorders Destruction of nerve cells in the brain (neurodegenerative disorder)

Info

Publication number
TH1601002196A
TH1601002196A TH1601002196A TH1601002196A TH1601002196A TH 1601002196 A TH1601002196 A TH 1601002196A TH 1601002196 A TH1601002196 A TH 1601002196A TH 1601002196 A TH1601002196 A TH 1601002196A TH 1601002196 A TH1601002196 A TH 1601002196A
Authority
TH
Thailand
Prior art keywords
semaphorin
destruction
brain
treatment
binding molecule
Prior art date
Application number
TH1601002196A
Other languages
Thai (th)
Other versions
TH178679B (en
TH178679A (en
Inventor
เอส สมิธ มัวไรซ์ เซาเดอเรอ วิลเลียม เจ โบเวอร์ส อลัน โจนาสัน เออร์เนสท์
Original Assignee
วิคซิเน็กซ์ อิงค์ (นิติบุคคลจัดตั้งขึ้นตามกฎหมายแห่งสหรัฐอเมริกา)
Filing date
Publication date
Application filed by วิคซิเน็กซ์ อิงค์ (นิติบุคคลจัดตั้งขึ้นตามกฎหมายแห่งสหรัฐอเมริกา) filed Critical วิคซิเน็กซ์ อิงค์ (นิติบุคคลจัดตั้งขึ้นตามกฎหมายแห่งสหรัฐอเมริกา)
Publication of TH178679B publication Critical patent/TH178679B/en
Publication of TH1601002196A publication Critical patent/TH1601002196A/en
Publication of TH178679A publication Critical patent/TH178679A/en

Links

Abstract

; ;

TH1601002196A 2014-10-21 Using a molecule that binds semaphorin -4D For the treatment of disease disorders that are Destruction of nerve cells in the brain (neurodegenerative disorder) TH178679A (en)

Publications (3)

Publication Number Publication Date
TH178679B TH178679B (en) 2018-08-09
TH1601002196A true TH1601002196A (en) 2018-08-09
TH178679A TH178679A (en) 2018-08-09

Family

ID=

Similar Documents

Publication Publication Date Title
IL263783A (en) Quinazoline and indole compounds to treat medical disorders
IL275720A (en) Use of semaphorin-4d binding molecules for treating neurodegenerative disorders
HK1231417A1 (en) Compounds for treating ophthalmic diseases and disorders
DK3185876T3 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
DK3307262T3 (en) Compounds for use in the treatment of neuromuscular disorders
BR112017007902A2 (en) compositions and methods for treating central nervous system disorders.
EA201790575A1 (en) TRIAZOLOPIRASINONS AS PDE1 INHIBITORS
BR112016029864A2 (en) methods and devices for treating further ocular disorders.
DK3119397T3 (en) Heterocyclic compounds for use in the treatment of PI3K-gamma-mediated disorders
DK3882250T3 (en) TETRAHYDROPYRANYL-AMINO-PYRROLOPYRIMIDINONE FOR USE IN THE TREATMENT OF BTK-MEDIATED DISORDERS
EP3137118A4 (en) Methods for treatment of disorders in the front of the eye utilizing nucleic acid molecules
EA201792157A1 (en) IMIDAZOPIRASINONS AS PDE1 INHIBITORS
DK3192524T3 (en) HGF PREPARATION SUITABLE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
DK3432895T3 (en) BLOOD PLATE PELLET FOR USE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
DK3439661T3 (en) PROCEDURES FOR THE TREATMENT OF EYE DISORDERS
DK3209295T3 (en) PROCEDURES FOR THE TREATMENT OF EYE DISORDERS
EA201691108A1 (en) Quinazoline-THF-Amines as PDE1 Inhibitors
DK3419672T5 (en) GENE THERAPY FOR THE TREATMENT OF RETINAL DEGENERATION DISEASE
ZA201901090B (en) Therapeutic combinations to treat red blood cell disorders
GB201607388D0 (en) Treatment of impulsivity-related disorders
EA201691773A1 (en) HALOGENATED HINAZOLIN-THF-AMINES AS PDE1 INHIBITORS
IL263494B1 (en) Use of lithium benzoate for treating central nervous system disorders
EA201691335A1 (en) HEXAHYDROFUROPYRROLES AS INHIBITORS PDE1
ITUA20161679A1 (en) COMPOSITION TO PREVENT AND TREAT NEURODEGENERATIVE PATHOLOGIES AND COGNITIVE DISORDERS
TH1601002196A (en) Use of semaphorin-4D binding molecule For the treatment of disease disorders Destruction of nerve cells in the brain (neurodegenerative disorder)